This article examines the clinical evidence regarding seizure risk with Wegovy, reviews recognised neurological side effects, and provides guidance on safety monitoring in line with UK regulatory standards from the MHRA, NICE, and current pharmacovigilance data
CONTINUE EXPLORING Looking for more
Apoptotic cell death in disease-current understanding of the NCCD 2023
GLP-1 receptor agonists (GLP-1 RAs) have been used to treat type 2 diabetes (T2D) for more than 15 years including Novo Nordisk products such as semaglutide and liraglutide that have been on the market for more than 10 years
Study Results In a one-month trial of liposomal glutathione (GSH), levels of glutathione markers increased significantly after just two weeks, by up to 40% in blood and 28% in plasma
and Mitsubishi Tanabe Pharma Corporation announced that Eli Lilly Japan received manufacturing and marketing authorization in Japan from the Japanese Ministry of Health, Labour and Welfare (MHLW) for Zepbound (non-proprietary name: tirzepatide